Have a personal or library account? Click to login
The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ Cover

The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ

Acta Pharmaceutica
Volume 69 (2019): Issue 1 (March 2019)
By: Xue Wang,  Shuaishuai Huang,  Xia Xin,  Yu Ren,  Guobin Weng and  Ping Wang  
Open Access
|Dec 2018

Authors

Xue Wang

Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China

Shuaishuai Huang

Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China

Xia Xin

Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China

Yu Ren

Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China

Guobin Weng

nbuurology@126.com

Department of Urologic Surgery, Ningbo Urology and Nephrology Hospital, Ningbo, China
Laboratory of Kidney Carcinoma, Urology and Nephrology Institute, Ningbo University, Ningbo, China

Ping Wang

Ningbo University, School of Medicine, Ningbo, China
DOI: https://doi.org/10.2478/acph-2019-0004 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 111 - 119
Accepted on: Aug 18, 2018
Published on: Dec 7, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
umbelliferone,
renal cell carcinoma,
p110γ,
anti-cancer activity
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Xue Wang, Shuaishuai Huang, Xia Xin, Yu Ren, Guobin Weng, Ping Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 1 (March 2019)Next article